Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Parke-Davis initiates QUASAR trial of quinapril

Aug. 28, 1997

Cardiovascular and antiarrhythmic activities of HNS-32

Aug. 27, 1997

Innothera describes agents for venous function deficiency

Aug. 27, 1997

TNF-alpha inhibitors for septic shock and other inflammatory diseases

Aug. 26, 1997

Medtronic initiates U.S. clinical trials of beStent Rival

Aug. 25, 1997

Xoma discloses rBPI-Ig fusion proteins

Aug. 25, 1997

PDGFr tyrosine kinase inhibitor with potential in atherosclerosis

Aug. 25, 1997

Merck KGaA begins development of cardioprotectant

Aug. 20, 1997

Viazem approved in 10 European countries

Aug. 20, 1997

Preclinical results on AVI-2221 for restenosis

Aug. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...